Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3071189/0/en/Larimar-Therapeutics-Reports-First-Quarter-2025-Financial-Results.html
24 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/24/3047689/0/en/Larimar-Therapeutics-Provides-Nomlabofusp-Development-Update-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
03 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/03/3036033/0/en/Larimar-Therapeutics-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference.html
23 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/23/3014608/0/en/Larimar-Therapeutics-Announces-Dosing-of-Adolescents-in-Nomlabofusp-Pediatric-Pharmacokinetic-Run-In-Study-for-Patients-with-Friedreich-s-Ataxia.html
18 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/18/2982603/0/en/Larimar-Therapeutics-Presents-Additional-Data-from-Phase-1-Studies-and-Phase-2-Dose-Exploration-Study-Supporting-the-Nomlabofusp-Clinical-Program-at-ICAR-2024.html
30 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/30/2971559/0/en/Larimar-Therapeutics-Reports-Third-Quarter-2024-Operating-and-Financial-Results.html
ABOUT THIS PAGE